Janus Henderson Group’s BioTelemetry, Inc. BEAT Stock Holding History

Janus Henderson Group’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-48,343	Closed	-$3.48M	–	1662
2020 Q4	$3.48M	Buy	48,343 +4,770	+11%	+$250K	﹤0.01%	1033
2020 Q3	$1.99M	Buy	43,573 +2,513	+6%	+$105K	﹤0.01%	1059
2020 Q2	$1.86M	Buy	41,060 +20,232	+97%	+$907K	﹤0.01%	1041
2020 Q1	$802K	Buy	20,828 +1,102	+6%	+$50.7K	﹤0.01%	1127
2019 Q4	$913K	Buy	19,726 +1,076	+6%	+$46.6K	﹤0.01%	1232
2019 Q3	$760K	Buy	18,650 +2,513	+16%	+$109K	﹤0.01%	1250
2019 Q2	$777K	Buy	16,137 +6,853	+74%	+$360K	﹤0.01%	1226
2019 Q1	$581K	Buy	+9,284	New	+$638K	﹤0.01%	1229

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Janus Henderson Group's BEAT Position: Q1 2021 in Review

Janus Henderson Group sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 48,343 shares — an estimated $3.48M sold.

Janus Henderson Group first reported a position in BEAT in Q1 2019 and held it in 8 quarters. The position peaked at $3.48M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Janus Henderson Group reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Janus Henderson Group sold 48,343 BioTelemetry, Inc. shares in Q1 2021, an estimated $3.48M.
Janus Henderson Group first reported a position in BioTelemetry, Inc. in Q1 2019 and held it in 8 quarters.
Janus Henderson Group's BioTelemetry, Inc. position peaked at $3.48M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Janus Henderson Group's 13F filing for Q1 2021, filed 17 May 2021.